Alida Biosciences has filed a notice of an exempt offering of securities to raise $8,520,384.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Alida Biosciences is raising up to $8,520,384.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Gudrun Stengel…